Offices – Austria
Explore all Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
Insights – Austria
Explore all insights
Expertise
Insights
Insights

CMS lawyers can provide future-facing advice for your business across a variety of specialisms and industries, worldwide.

Explore topics
Offices
Global Reach
Global Reach

Apart from offering expert legal consultancy for local jurisdictions, CMS partners up with you to effectively navigate the complexities of global business and legal environments.

Explore our reach
CMS Austria
Insights
About CMS

Select your region

Gabriela Staber
Partner

Gabriela Staber

Languages
  • German
  • English

Gabriela Staber is an attorney-at-law specialising in Intellectual Property and Unfair Competition Law with a sector focus on Life Sciences & Healthcare and TMC - Technology, Media & Telecommunications.

In addition to dispute resolution, her expertise includes the criminal prosecution of infringements, the licensing of intellectual property rights, the negotiation of cross-border and international agreements, the protection of designs, know-how and trade secrets, the management of trademark portfolios, service invention law, software law, advertising and product labelling as well as antitrust issues related to intellectual property rights.

Gabriela regularly publishes in specialist journals and is an editor of the Austrian Journal of Medical and Health Law. She has co-authored commentaries on the European Union Trademark Regulation and the Community Design Regulation. She regularly gives lectures and training seminars in the abovementioned fields.

Gabriela is consistently awarded the highest rankings for her notable expertise, such as Tier 1 by Chambers Europe, and has been recommended as an outstanding expert by JUVE, World Trademark Review (WTR) and Legal 500 for several years in a row.

Awards & Recognitions
01
  • Quote
    "Gabriela Staber is always solution-oriented and provides excellent client service and expertise."
    Chambers Europe, 2024
  • Quote
    "Gabriela Staber makes complex issues easy to understand and always exceeds expectations."
    WTR1000, 2024
  • Quote
    "We had great cooperation with Gabriela, who was responsive and gave clear advice showing a good understanding of our priorities."
    Chambers Europe, 2023
  • Quote
    "Gabriela Staber stands out."
    The Legal 500, 2023
  • Quote
    "She is right up there as a pharmaceutical specialist."
    Chambers Europe, 2023

Publications

  • EU-Arzneimittelreform: Großer Wurf oder Bedrohung für den europäischen Pharmastandort?, JMG 2024, 153.
  • OLG Bremen: Werbung mit den Begriffen „nachhaltig“, „umweltfreundlich“ oder „ressourcenschonend“ erfordert eine Konkretisierung, NR 2024, 72.
  • Fälschungsschutz versus Markenrechte – Wann ist das Umpacken, Rebranding und Debranding von Arzneimitteln erlaubt?, JMG 2023, 152.
  • Patientenunterstützungsprogramme – Förderung der Therapietreue oder unzulässige Arzneimittelwerbung, JMG 2022, 231.
  • Impfschadengesetz: Verschuldensunabhängige Entschädigung für Schäden durch eine COVID-19 Impfung, JMG 2022, 126.
  • Scharf/Staber, Private Enforcement von Datenschutzverstößen – noch immer alles offen?, ecolex 2022, 153.
  • Mahfoozpour/Staber, Spannungsfeld „Greenwashing“: Eine Rechtsprechungsübersicht, NR 2022, 62.
  • Gilt die Konformitätsvermutung für Medizinprodukte auch im UWG-Prozess?, RdM 2021/112.
  • Glosse zu OGH 22.9.2020, 4 Ob 135/20m, ecolex 2021/113.
  • Scharf/Staber, Update zur lauterkeitsrechtlichen Verfolgbarkeit von Datenschutzverstößen, ecolex 2020, 909.
  • Scharf/Staber, Abmahnungen wegen Verstößen gegen die DSGVO - Die Ruhe vor dem Sturm?, ecolex 9/2019, 787.
  • Staber in Hasselblatt (Hrsg.), European Union Trademark Regulation2 Art. 111–118 (Beck, Hart, Nomos 2018).
  • Staber in Hasselblatt (Hrsg.), Community Design Regulation Art. 55–58 (Beck, Hart, Nomos 2018).
  • Staber/Engin-Deniz/KaindlDistribution and Marketing of Drugs in Austria, Country Q&A (Thomson Reuters 2018). 
  • Staber/Winter, Übernahme der Konventionalstrafe nicht mehr wettbewerbswidrig, ecolex 2015, 55.

Memberships & Roles

  • International Trademark Association (INTA)
  • Pharmaceutical Trade Marks Group (PTMG)
  • Austrian Bar Association

Awards & Rankings

  • Gabriela continuously achieves the highest ranks for her notable skills such as Tier 1 by Chambers Europe and has been recommended by JUVE, World Trademark Review (WTR) and Legal 500 as an expert that “stands out” for several years in a row.

Education

  • 2011 - Admitted to practice law in New York and Massachusetts
  • 2010 - LL.M., Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School, Boston
  • 2007 - Admitted to the Austrian Bar
  • 2004 - Dr.in iur., Corporate Law (Antitrust Law), University of Vienna
  • 2001 - LL.M., European Law, King's College London
  • 1999 - Mag.a iur., Law, University of Vienna

Gabriela Staber is an attorney-at-law specialising in Intellectual Property and Unfair Competition Law with a sector focus on Life Sciences & Healthcare and TMC - Technology, Media & Telecommunications.

She advises on issues related to the marketing and distribution of pharmaceuticals and medical devices as well as the protection of intellectual property. Her expertise includes advertising and product labelling, compliance, restructuring of distribution systems, reimbursement / market access, clinical trials, licensing, anti-counterfeiting and parallel import measures and dispute resolution. Her clients include pharmaceutical, medical device and biotechnology companies, healthcare start-ups and online pharmacies.

Gabriela regularly publishes in specialist journals and is an editor of the Austrian Journal of Medical and Health Law. She has co-authored commentaries on the European Union Trademark Regulation and the Community Design Regulation. She regularly gives lectures and training seminars in the abovementioned fields.

Gabriela is consistently awarded the highest rankings for her notable expertise, such as Tier 1 by Chambers Europe, and has been recommended as an outstanding expert by JUVE, World Trademark Review (WTR) and Legal 500 for several years in a row.

Awards & Recognitions
01
  • Quote
    "Gabriela Staber is always solution-oriented and provides excellent client service and expertise."
    Chambers Europe, 2024
  • Quote
    "Gabriela Staber makes complex issues easy to understand and always exceeds expectations."
    WTR1000, 2024
  • Quote
    "We had great cooperation with Gabriela, who was responsive and gave clear advice showing a good understanding of our priorities."
    Chambers Europe, 2023
  • Quote
    "Gabriela Staber stands out."
    The Legal 500, 2023

Publications

  • EU-Arzneimittelreform: Großer Wurf oder Bedrohung für den europäischen Pharmastandort?, JMG 2024, 153.
  • OLG Bremen: Werbung mit den Begriffen „nachhaltig“, „umweltfreundlich“ oder „ressourcenschonend“ erfordert eine Konkretisierung, NR 2024, 72.
  • Fälschungsschutz versus Markenrechte – Wann ist das Umpacken, Rebranding und Debranding von Arzneimitteln erlaubt?, JMG 2023, 152.
  • Patientenunterstützungsprogramme – Förderung der Therapietreue oder unzulässige Arzneimittelwerbung, JMG 2022, 231.
  • Impfschadengesetz: Verschuldensunabhängige Entschädigung für Schäden durch eine COVID-19 Impfung, JMG 2022, 126.
  • Scharf/Staber, Private Enforcement von Datenschutzverstößen – noch immer alles offen?, ecolex 2022, 153.
  • Mahfoozpour/Staber, Spannungsfeld „Greenwashing“: Eine Rechtsprechungsübersicht, NR 2022, 62.
  • Gilt die Konformitätsvermutung für Medizinprodukte auch im UWG-Prozess?, RdM 2021/112.
  • Glosse zu OGH 22.9.2020, 4 Ob 135/20m, ecolex 2021/113.
  • Scharf/Staber, Update zur lauterkeitsrechtlichen Verfolgbarkeit von Datenschutzverstößen, ecolex 2020, 909.
  • Scharf/Staber, Abmahnungen wegen Verstößen gegen die DSGVO - Die Ruhe vor dem Sturm?, ecolex 9/2019, 787.
  • Staber in Hasselblatt (Hrsg.), European Union Trademark Regulation2 Art. 111–118 (Beck, Hart, Nomos 2018).
  • Staber in Hasselblatt (Hrsg.), Community Design Regulation Art. 55–58 (Beck, Hart, Nomos 2018).
  • Staber/Engin-Deniz/KaindlDistribution and Marketing of Drugs in Austria, Country Q&A (Thomson Reuters 2018). 
  • Staber/Winter, Übernahme der Konventionalstrafe nicht mehr wettbewerbswidrig, ecolex 2015, 55.

Memberships & Roles

  • International Trademark Association (INTA)
  • Pharmaceutical Trade Marks Group (PTMG)
  • Austrian Bar Association

Awards & Rankings

  • Gabriela continuously achieves the highest ranks for her notable skills such as Tier 1 by Chambers Europe and has been recommended by JUVE, World Trademark Review (WTR) and Legal 500 as an expert that “stands out” for several years in a row.

Education

  • 2011 - Admitted to practice law in New York and Massachusetts
  • 2010 - LL.M., Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School, Boston
  • 2007 - Admitted to the Austrian Bar
  • 2004 - Dr.in iur., Corporate Law (Antitrust Law), University of Vienna
  • 2001 - LL.M., European Law, King's College London
  • 1999 - Mag.a iur., Law, University of Vienna

Gabriela Staber is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications).  Her practice areas include television, telecommunications, new media and sports. Her expertise comprises the marketing of media rights, short reports, regulatory broadcasting and telecommunications law, advertising, licensing, copyright protection of media content, trademark law, protection of personal rights as well as reputation management and litigation and proceedings before regulatory authorities in these areas.
Her clients include broadcasters, organisers of major sporting events, media companies and telecommunications companies.

Gabriela regularly publishes in specialist journals and is an editor of the Austrian Journal of Medical and Health Law. She has co-authored commentaries on the European Union Trademark Regulation and the Community Design Regulation. She regularly gives lectures and training seminars in the abovementioned fields. 

Gabriela is consistently awarded the highest rankings for her notable expertise, such as Tier 1 by Chambers Europe, and has been recommended as an outstanding expert by JUVE, World Trademark Review (WTR) and Legal 500 for several years in a row. 

Awards & Recognitions
01
  • Quote
    "Gabriela Staber is always solution-oriented and provides excellent client service and expertise."
    Chambers Europe, 2024
  • Quote
    "Gabriela Staber makes complex issues easy to understand and always exceeds expectations."
    WTR1000, 2024
  • Quote
    "We had great cooperation with Gabriela, who was responsive and gave clear advice showing a good understanding of our priorities."
    Chambers Europe, 2023
  • Quote
    "Gabriela Staber stands out."
    The Legal 500, 2023
  • Quote
    "She is right up there as a pharmaceutical specialist."
    Chambers Europe, 2023

Publications

  • EU-Arzneimittelreform: Großer Wurf oder Bedrohung für den europäischen Pharmastandort?, JMG 2024, 153.
  • OLG Bremen: Werbung mit den Begriffen „nachhaltig“, „umweltfreundlich“ oder „ressourcenschonend“ erfordert eine Konkretisierung, NR 2024, 72.
  • Fälschungsschutz versus Markenrechte – Wann ist das Umpacken, Rebranding und Debranding von Arzneimitteln erlaubt?, JMG 2023, 152.
  • Patientenunterstützungsprogramme – Förderung der Therapietreue oder unzulässige Arzneimittelwerbung, JMG 2022, 231.
  • Impfschadengesetz: Verschuldensunabhängige Entschädigung für Schäden durch eine COVID-19 Impfung, JMG 2022, 126.
  • Scharf/Staber, Private Enforcement von Datenschutzverstößen – noch immer alles offen?, ecolex 2022, 153.
  • Mahfoozpour/Staber, Spannungsfeld „Greenwashing“: Eine Rechtsprechungsübersicht, NR 2022, 62.
  • Gilt die Konformitätsvermutung für Medizinprodukte auch im UWG-Prozess?, RdM 2021/112.
  • Glosse zu OGH 22.9.2020, 4 Ob 135/20m, ecolex 2021/113.
  • Scharf/Staber, Update zur lauterkeitsrechtlichen Verfolgbarkeit von Datenschutzverstößen, ecolex 2020, 909.
  • Scharf/Staber, Abmahnungen wegen Verstößen gegen die DSGVO - Die Ruhe vor dem Sturm?, ecolex 9/2019, 787.
  • Staber in Hasselblatt (Hrsg.), European Union Trademark Regulation2 Art. 111–118 (Beck, Hart, Nomos 2018).
  • Staber in Hasselblatt (Hrsg.), Community Design Regulation Art. 55–58 (Beck, Hart, Nomos 2018).
  • Staber/Engin-Deniz/KaindlDistribution and Marketing of Drugs in Austria, Country Q&A (Thomson Reuters 2018). 
  • Staber/Winter, Übernahme der Konventionalstrafe nicht mehr wettbewerbswidrig, ecolex 2015, 55.

Memberships & Roles

  • International Trademark Association (INTA)
  • Pharmaceutical Trade Marks Group (PTMG)
  • Austrian Bar Association

Awards & Rankings

  • Gabriela continuously achieves the highest ranks for her notable skills such as Tier 1 by Chambers Europe and has been recommended by JUVE, World Trademark Review (WTR) and Legal 500 as an expert that “stands out” for several years in a row.

Education

  • 2011 - Admitted to practice law in New York and Massachusetts
  • 2010 - LL.M., Intellectual Property and Information Technology Law & U.S. Law, Suffolk Law School, Boston
  • 2007 - Admitted to the Austrian Bar
  • 2004 - Dr.in iur., Corporate Law (Antitrust Law), University of Vienna
  • 2001 - LL.M., European Law, King's College London
  • 1999 - Mag.a iur., Law, University of Vienna